Classification
- Anatomical main groupNNervous system
- Therapeutic subgroupN06
- Pharmacological subgroupN06B
- Chemical subgroupN06BA
- Chemical substanceN06BA09Atomoxetine
Where it is registered
Each register with its number of medicines and a few of them.
Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
CBG-MEB · 42 medicines
MS · 38 medicines · Historical list
SFDA · 13 medicines · Historical list
HALMED · 7 medicines
PHARMAC · 7 medicines
Show all 7Anvisa · 4 medicines
FDA · 3 medicines
Every register, a page at a time. Strengths and packs are on each medicine’s page.
58 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Atomoxetina Cinfa 10 MG Capsulas Duras Efg | Spain | 11.4278 mg | cápsula dura | Marketed | Laboratorios Cinfa S.A. |
| Atomoxetina Cinfa 18 MG Capsulas Duras Efg | Spain | 20.57 mg | cápsula dura | Marketed | Laboratorios Cinfa S.A. |
| Atomoxetina Cinfa 25 MG Capsulas Duras Efg | Spain | 28.5695 mg | cápsula dura | Marketed | Laboratorios Cinfa S.A. |
| Atomoxetina Cinfa 40 MG Capsulas Duras Efg | Spain | 45.7111 mg | cápsula dura | Marketed | Laboratorios Cinfa S.A. |
| Atomoxetina Cinfa 60 MG Capsulas Duras Efg | Spain | 68.5667 mg | cápsula dura | Marketed | Laboratorios Cinfa S.A. |
| Atomoxetina Cinfa 80 MG Capsulas Duras Efg | Spain | 91.4223 mg | cápsula dura | Marketed | Laboratorios Cinfa S.A. |
| Atomoxetina Cinfa 100 MG Capsulas Duras Efg | Spain | 114.2779 mg | cápsula dura | Marketed | Laboratorios Cinfa S.A. |
| Atomoxetina Tarbis 10 MG Cápsulas Duras Efg | Spain | 11,428 mg | cápsula dura | Marketed | Tarbis Farma S.L. |
| Atomoxetina Tarbis 18 MG Cápsulas Duras Efg | Spain | 20,57 mg | cápsula dura | Marketed | Tarbis Farma S.L. |
| Atomoxetina Tarbis 25 MG Cápsulas Duras Efg | Spain | 28,570 mg | cápsula dura | Marketed | Tarbis Farma S.L. |
| Atomoxetina Tarbis 40 MG Cápsulas Duras Efg | Spain | 45,712 mg | cápsula dura | Marketed | Tarbis Farma S.L. |
| Atomoxetina Tarbis 60 MG Cápsulas Duras Efg | Spain | 68,567 mg | cápsula dura | Marketed | Tarbis Farma S.L. |
| Atomoxetina Tarbis 80 MG Cápsulas Duras Efg | Spain | 91,422 mg | cápsula dura | Marketed | Tarbis Farma S.L. |
| Atomoxetina Tarbis 100 MG Cápsulas Duras Efg | Spain | 114,27 mg | cápsula dura | Marketed | Tarbis Farma S.L. |
| Atomoxetina Aurovitas 10 MG Capsulas Duras Efg | Spain | 11.428 mg | cápsula dura | Authorised | Aurovitas Spain, S.A.U. |
| Atomoxetina Aurovitas 18 MG Capsulas Duras Efg | Spain | 20.570 mg | cápsula dura | Authorised | Aurovitas Spain, S.A.U. |
| Atomoxetina Aurovitas 25 MG Capsulas Duras Efg | Spain | 28.569 mg | cápsula dura | Authorised | Aurovitas Spain, S.A.U. |
| Atomoxetina Aurovitas 40 MG Capsulas Duras Efg | Spain | 45.711 mg | cápsula dura | Authorised | Aurovitas Spain, S.A.U. |
| Atomoxetina Aurovitas 60 MG Capsulas Duras Efg | Spain | 68.567 mg | cápsula dura | Authorised | Aurovitas Spain, S.A.U. |
| Atomoxetina Aurovitas 80 MG Capsulas Duras Efg | Spain | 91.422 mg | cápsula dura | Authorised | Aurovitas Spain, S.A.U. |
| Atomoxetina Macleods 10 MG Capsulas Duras Efg | Spain | 11.4 mg | cápsula dura | Authorised | Macleods Pharma Espana S.L.U. |
| Atomoxetina Macleods 18 MG Capsulas Duras Efg | Spain | 20.52 mg | cápsula dura | Authorised | Macleods Pharma Espana S.L.U. |
| Atomoxetina Macleods 25 MG Capsulas Duras Efg | Spain | 28.5 mg | cápsula dura | Authorised | Macleods Pharma Espana S.L.U. |
| Atomoxetina Macleods 40 MG Capsulas Duras Efg | Spain | 45.6 mg | cápsula dura | Authorised | Macleods Pharma Espana S.L.U. |
| Atomoxetina Macleods 60 MG Capsulas Duras Efg | Spain | 68.4 mg | cápsula dura | Authorised | Macleods Pharma Espana S.L.U. |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.